3136 results for «2675»
3136 results
Align for the future with the Myval Octapro transcatheter heart valve series
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.
Clinical insights are backed by key data...
My approach for a calcified bifurcation lesion
20 May 2025 – From EuroPCR 2025
This session provides a comprehensive approach to managing calcified bifurcation lesions. Learn how to interpret angiographic and intravascular imaging, plan interventions with appropriate devices for simplicity and safety, and evaluate final results to understand their clinical impact through real cases.
Challenges and solutions in an expanding TAVI world
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session addresses key challenges and emerging solutions in today’s rapidly evolving TAVI landscape. It presents the latest evidence on valve replacement in low-risk patients with aortic stenosis, alongside strategies for navigating the complexities of lifetime management in TAVI candidates. The programme features a...
Integrative step-by-step approach to perform successful CTO interventions: from angiographic evaluation to strategy selection
20 May 2025 – From EuroPCR 2025
Master the integrative step-by-step approach to successful chronic total occlusion (CTO) interventions. This session emphasizes systematic angiographic evaluation and strategy selection ranging from simple to complex techniques, supplemented by blinded case discussions for practical learning.
China experience in TAVI evolution
22 May 2025 – From EuroPCR 2025
This session highlights key innovations and recent research from China in the field of transcatheter aortic valve implantation (TAVI). Leading cardiovascular specialist present new data on pacing strategies, comparing left bundle branch area pacing with traditional right ventricular pacing in TAVI patients. They also explore the use...
Novelty in no-reflow management in STEMI patients
20 May 2025 – From EuroPCR 2025
Discover novel approaches to manage no-reflow phenomenon in STEMI patients. This session covers innovative therapies including the OPTI-STEMI trial strategies, mechanical thrombectomy, pharmacological interventions with Cangrelor, and super saturated oxygen therapy targeting coronary microcirculation preservation.
Enhancing clipping solutions for durable long-term patient outcomes
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session delves into the evolving strategies for mitral and tricuspid TEER, backed by fresh data and real-world insights. Review the latest evidence from the TRILUMINATE Pivotal and bRIGHT studies, and see how TR phenotypes can guide patient selection for more durable outcomes. Discover...
Evolving bifurcation treatment practices: drug-coated balloons, angio-based FFR, and side branch optimisation
20 May 2025 – From EuroPCR 2025
Explore how bifurcation treatment is evolving with the integration of drug-coated balloons, angio-based FFR, and advanced side branch optimisation. This EuroPCR 2025 session highlights why DCB is gaining traction for bifurcation lesions and introduces the upcoming EBC-DCB trial comparing a stepwise DCB strategy to provisional DES...
How to build a tricuspid programme?
20 May 2025 – From EuroPCR 2025
Learn how to build a successful tricuspid valve programme with a focus on patient screening protocols, heart team roles, and post-procedural management. Gain expert perspectives on organizational requirements, referral optimization, multidisciplinary collaboration, and quality assessment for tricuspid interventions.
Challenging scenarios in patient with multivessel disease
20 May 2025 – From EuroPCR 2025
Explore challenging clinical scenarios in patients with multivessel coronary artery disease. This session presents complex cases such as coronary aneurysms, failed bypass grafts, limitations of intravascular lithotripsy, and rare pathologies like Takayasu’s arteritis, highlighting decision-making and advanced intervention strategies.
Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice
21 May 2025 – From EuroPCR 2025
This session presents the latest updates on the novel Myval Octapro transcatheter heart valve (THV), based on one year of real-world clinical experience. Experts share practical tips and clinical cases that highlight how this innovative device can improve TAVI patient outcomes. The session also addresses imaging and...
DCB in de novo lesions: new valid option?
20 May 2025 – From EuroPCR 2025
Explore the emerging role of drug-coated balloons (DCB) in treating de novo coronary lesions. This session discusses complexity management, comparisons with drug-eluting stents (DES), and the potential of DCBs as valuable alternatives, especially in high bleeding risk patients.
Challenging scenarios in acute coronary syndrome
20 May 2025 – From EuroPCR 2025
This session presents challenging acute coronary syndrome (ACS) cases with unusual presentations and complications. Learn from cases involving myocarditis mimics, coronary aneurysms, rescue fibrinolysis during PCI, and STEMI complicated by cardiogenic shock, highlighting diagnostic and therapeutic nuances.
New perspectives in 3D calcium visualisation with CT and angiography for complex PCI
21 May 2025 – From EuroPCR 2025
Thanks to this EuroPCR 2025 session, discover new perspectives on 3D calcium visualisation combining advanced imaging techniques like 3DStent, IVUS, and 3D angiography to enhance complex PCI. Learn from detailed calcium mapping and plaque assessment to guide strategic decisions and see these innovations applied in practice...
Novel Hertz Contact Intravascular Lithotripsy: could we achieve more in calcium modification?
22 May 2025 – From EuroPCR 2025
Discover how the novel Hertz Contact Intravascular Lithotripsy (IVL) is pushing the boundaries of calcium modification in challenging coronary lesions.
This EuroPCR 2025 session shares real-world insights confirming the promising results of the PINNACLE I trial, with LithiX IVL proving safe and effective across eccentric, concentric, and...
Best companion's case on complications for stable coronary artery disease PCI: episode 1
20 May 2025 – From EuroPCR 2025
This session focuses on managing complications during PCI for stable coronary artery disease through real-world case presentations. Topics include severe dissections, unexpected procedural complications, and escalation of routine interventions, providing practical insights for complication navigation.
